Accuray (ARAY) Income from Non-Controlling Interests (2011 - 2025)
Accuray (ARAY) reported Income from Non-Controlling Interests of $439000.0 for Q2 2025, up 709.72% on a YoY basis from $54216.1 in Q2 2024, and down 80.89% quarter-over-quarter from $2.3 million in Q4 2024.
Accuray (ARAY) Income from Non-Controlling Interests (2011 - 2025) Analysis & Trends
Accuray has reported Income from Non-Controlling Interests for 8 years, with the latest figure at $439000.0 in Q2 2025.
- For the quarter ending Q2 2025, Income from Non-Controlling Interests rose 709.72% year-over-year to $439000.0; the trailing twelve-month figure through Jun 2025 stood at $4.3 million (up 346.44% YoY), and the FY2025 full-year result was $439000.0, up 709.72% from the prior year.
- Income from Non-Controlling Interests for Q2 2025 stood at $439000.0, down from $2.3 million in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $2.3 million in Q4 2024, with the low at -$832000.0 in Q3 2021.
- Historically, Income from Non-Controlling Interests has averaged $441769.2 across 5 years, with a median of $431000.0 in 2023.
- Annual changes were most pronounced in 2021 — Income from Non-Controlling Interests plunged 1114.29% — and 2025, when it jumped 709.72%.
- Accuray's Income from Non-Controlling Interests stood at $740000.0 in 2021, then jumped by 162.97% to $1.9 million in 2022, then tumbled by 47.38% to $1.0 million in 2023, then surged by 124.32% to $2.3 million in 2024, then slumped by 80.89% to $439000.0 in 2025.
- The last three Income from Non-Controlling Interests figures came in at $439000.0 (Q2 2025), $2.3 million (Q4 2024), and $1.6 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 6.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -5.85 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 22.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 100,000.00 |
| 10 | Accuray | 41,092.55 | -38.49 Mn | 25.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 439,000.00 |
| Dec 31, 2024 | 2.30 Mn |
| Sep 30, 2024 | 1.60 Mn |
| Jun 30, 2024 | -72,000.00 |
| Dec 31, 2023 | 1.02 Mn |
| Sep 30, 2023 | -427,000.00 |
| Jun 30, 2023 | 431,000.00 |
| Dec 31, 2022 | 1.95 Mn |
| Sep 30, 2022 | -699,000.00 |
| Jun 30, 2022 | -368,000.00 |
| Dec 31, 2021 | 740,000.00 |
| Sep 30, 2021 | -832,000.00 |
| Jun 30, 2021 | -340,000.00 |
| Dec 31, 2020 | 1.02 Mn |
| Sep 30, 2020 | 1.09 Mn |
| Jun 30, 2020 | -28,000.00 |
| Mar 31, 2020 | -149,000.00 |
| Dec 31, 2012 | -1.18 Mn |
| Sep 30, 2012 | -12.11 Mn |
| Jun 30, 2012 | -1.38 Mn |